Terapia Ranbaxy
8 articole · RSS
Terapia Ranbaxy’s Sales Up 9.5% In 1H Due To Launch Of New OTC Drugs
Romanian pharmaceutical company Terapia Ranbaxy, the largest local generic drug producer, reported sales of around 238 million lei (EUR53.6 million) locally in the first half of 2014, up 9.5% on the year, due to the launch of seven new products on the segment...
Terapia Ranbaxy To Pay RON205M Dividend From 2011-2013 Profits
Romania’s largest generic drug maker Terapia Ranbaxy, the local unit of Indian pharmaceuticals group Ranbaxy Laboratories, will pay out its shareholders a total dividend of 205 million lei (...
Terapia Ranbaxy Invests EUR6.6 Million In R&D Center
Terapia Ranbaxy, the largest generic drug producer in Romania, will invest 29.2 million lei (almost EUR6.6 million) in a research and development center in Cluj-Napoca (NW Romania) to make n...
Terapia Ranbaxy 3Q Turnover Up 5%, To RON110M
Romanian pharmaceutical company Terapia Ranbaxy, the largest local generic drug producer, registered a growth of around 5% in turnover in the third quarter, to RON110 million (EUR24.7 millio...
Ranbaxy CEO: Romania Is Becoming A Hub For Us, Exports To 30 Countries
Romania is a key market for the Indian pharmaceutical producer Ranbaxy, which owns Terapia Cluj plant in this country, its chief executive officer and managing director Arun Sawhney says. Ra...
Terapia Ranbaxy 1H Sales Up 8% On Year To RON250M
Romanian pharmaceutical company Terapia Ranbaxy, the largest local generic drug producer, registered turnover of 250 million lei (EUR56 million) in the first half of 2013, up 8% on the year.
Terapia Ranbaxy Sales Up 10% In 1Q, To RON111M
Sales of Terapia Ranbaxy, Romania’s biggest generic drugs producer, increased some 10% in the first quarter of the year, to RON111 million, with the launch of new products and a higher empha...
Terapia Ranbaxy Beats Rival Europharm To The Top Spot In 2011
Terapia Ranbaxy in Cluj became Romania’s largest drug maker last year, leaving rival Europharm behind by just EUR3 million. Terapia came close to EUR100 million in revenue and had the highes...